André Richters

André Richters is a Principal Scientist at Lundbeck, with a focus on medicinal chemistry and drug discovery, possessing extensive experience in managing chemistry teams and contributing to degrader programs. Prior roles include Senior Scientist positions at Plexium, where André led the development of small molecule libraries and managed chemistry CROs, and significant research positions at prestigious institutions such as the MIT Koch Institute and the Broad Institute, where André worked on targeted degradation technologies, including Lysosome Targeting Chimeras and selective kinase inhibitors. André's academic background includes a PhD from the Max-Planck Institute for Molecular Physiology and postdoctoral research at TU Dortmund University, with a solid foundation in chemical biology and kinase inhibitors.